Frost & Sullivan

AUGUST 9, 2021

Over the next two to three years, biopharma companies also will highly invest in DTx solutions, enabling the subsidized cost to patients in exchange for marketing and access to patient data.

Life science 98

Life science Biopharma Government Biopharmaceuticals 98

Frost & Sullivan

AUGUST 9, 2021

Over the next two to three years, biopharma companies also will highly invest in DTx solutions, enabling the subsidized cost to patients in exchange for marketing and access to patient data.

Life science 90

Life science Biopharma Government Biopharmaceuticals 90

Frost & Sullivan

JULY 22, 2021

As a result, academic labs and small biotech companies are accelerating RNA therapeutics research, alongside Tier 1 biopharmaceutical companies.” . “RNAs are relatively easy to manufacture, cost-effective, and can act on undruggable targets.

Biotech 98

Biotech Biopharmaceuticals Biotechnology Government 98

Frost & Sullivan

APRIL 25, 2023

Emmes is a full-service, global Clinical Research Organization (CRO) committed to promoting public health and biopharmaceutical innovation. The company collaborates with biopharmaceutical, governmental, non-profit, and academic organizations to enhance its value proposition and meet client demands.

Biopharmaceuticals 52

Biopharmaceuticals Biopharma Biotechnology Contract research organization 52

Frost & Sullivan

AUGUST 23, 2023

The combination of claims and EHR data, an expanding incorporation of genomic insights, and a continued emphasis on RWE and diversity, make Optum the partner of choice for biopharmaceutical (biopharma) companies seeking to create higher-value treatments while accelerating their time to market.

Life science 52

Life science Biopharmaceuticals Biopharma Partnering capability and readiness 52

Frost & Sullivan

MAY 3, 2023

The company stands out in the industry as it works hard to deliver high-quality scientific services while identifying solutions for big biopharma. George Clinical upholds its agility and responsiveness towards clients with nearly 500 employees, making it more flexible, adaptable, and faster than competitors with more employees.

Contract research organization 52

Contract research organization Biopharmaceuticals Biopharma Business development 52

Frost & Sullivan

APRIL 3, 2024

Simtra BioPharma Solutions announced over $250 million expansion of its sterile fill/finish manufacturing campus in Bloomington, Indiana. SCHOTT Pharma announced expansion plans in the US to meet the growing demand for mRNA vaccines, GLP1 drugs, and biologics.

Biopharmaceuticals 59

Biopharmaceuticals Biopharma Biotechnology Life science 59

Frost & Sullivan

JUNE 24, 2024

Biomarker Driven Treatments for Lung Cancers Continue to Gain Prominence The impetus in the field of lung cancer research is sustained by the emergence of new data, which showcased the encouraging clinical outcomes presented by major biopharmaceutical companies.

Biopharmaceuticals 52

Biopharmaceuticals Biopharma Collaboration Ecosystems 52

Jake Jorgovan

FEBRUARY 5, 2025

Updated: February 2025 Biopharmaceutical consultants and consulting firms play a pivotal role in guiding companies through the intricate landscape of drug development, regulatory compliance, and market strategies. The Value of a Biopharma Consulting Firm Beyond mere compliance, these consultants offer strategic vision.

Biopharmaceuticals 130

Biopharmaceuticals Biopharma Biotech Life science 130

Jake Jorgovan

FEBRUARY 5, 2025

JGB Biopharma Consulting, Inc. JGB Biopharma Consulting, Inc. is a reputable firm specializing in consulting, recruitment, and personnel placement within the biopharmaceutical sector. Their approach is highly personalized, ensuring that both companies and candidates find the perfect fit.

Biotechnology 130

Biotechnology Life science Biotech Biopharma 130